Venus Remedies Limited has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 144.184 crores during the period ended March 31, 2022 as compared to Rs. 125.560 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 0.232 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 5.646 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 0.17 for the period ended March 31, 2022 as compared to Rs. 4.22 for the period ended December 31, 2021.
Total Income | ₹ 144.184 crs | ₹125.560 crs | 14.83% |
Net Profit | ₹0.232 crs | ₹5.646 crs | -95.89% |
EPS | ₹0.17 | ₹4.22 | -95.97% |
Financial Results (Q4 FY2022) - YoY Comparison The company has reported total income of Rs. 144.184 crores during the period ended March 31, 2022 as compared to Rs.114.863 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.0.232 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.35.110 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.0.17 for the period ended March 31, 2022 as compared to Rs.28.45 for the period ended March 31, 2021.
Total Income | ₹ 144.184 crs | ₹114.863 crs | 25.53% |
Net Profit | ₹0.232 crs | ₹35.110 crs | -99.34% |
EPS | ₹0.17 | ₹28.45 | -99.40% |
Financial Results (Year Ended FY2022) - YoY Comparison The company has reported total income of Rs.606.959 crores during the Financial Year ended March 31, 2022 as compared to Rs.567.753 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.40.724 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.61.765 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.30.86 for the Financial Year ended March 31, 2022 as compared to Rs.50.04 for the Financial Year ended March 31, 2021.
Total Income | ₹606.959 crs | ₹567.753 crs | 6.91% |
Net Profit | ₹40.724 crs | ₹61.765 crs | -34.07% |
EPS | ₹30.86 | ₹50.04 | -38.33% |
Shares of Venus Remedies Limited was last trading in BSE at Rs. 221.85 as compared to the previous close of Rs. 217.75. The total number of shares traded during the day was 5126 in over 595 trades.
The stock hit an intraday high of Rs. 228.10 and intraday low of 216.05. The net turnover during the day was Rs. 1140870.00.
Source : Equity Bulls
Keywords
VenusRemedies
Q4FY22
FY2022
ResultUpdate